대한수의학회지 (Korean Journal of Veterinary Research)

  • 제62권3호
  • /
  • Pages.22.1-22.4
  • /
  • 2022
  • /
  • 2466-1384(pISSN)
  • /
  • 2466-1392(eISSN)
대한수의학회 (The Korean Society of Veterinary Science)
권호 표지
DOI QR코드

DOI QR Code

Sodium nitroprusside on acute cardiogenic pulmonary edema in dogs: case reports

  • Han, Mangil (Department of Veterinary Internal Medicine and Institute of Veterinary Science, College of Veterinary Medicine, Kangwon National University) ;
  • Kim, Yoonhwan (Department of Veterinary Internal Medicine and Institute of Veterinary Science, College of Veterinary Medicine, Kangwon National University) ;
  • Jeong, Yunho (Department of Veterinary Internal Medicine and Institute of Veterinary Science, College of Veterinary Medicine, Kangwon National University) ;
  • Ahn, Jin-Ok (Department of Veterinary Internal Medicine and Institute of Veterinary Science, College of Veterinary Medicine, Kangwon National University) ;
  • Chung, Jin-Young (Department of Veterinary Internal Medicine and Institute of Veterinary Science, College of Veterinary Medicine, Kangwon National University)
  • 투고 : 2022.05.03
  • 심사 : 2022.07.20
  • 발행 : 2022.09.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

This study reports the efficacy of the vasodilator sodium nitroprusside (SNP), for treatment of acute cardiogenic pulmonary edema in dogs. For this study, the patients were divided into the SNP only treatment group, the SNP, furosemide and dobutamine treatment group, and non-SNP treatment group. Seven dogs, 6 dogs and 2 dogs were favorable responders in SNP only group, group with SNP, furosemide and dobutamine and non-SNP treatment group, each. The results of this study suggest that SNP can be an effective alternative therapy for dogs with acute cardiogenic pulmonary edema.

키워드

과제정보

This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2014R1A1A1004339, NRF-2020R1F1A1073007).

참고문헌

  1. Johnson MR. Acute pulmonary edema. Curr Treat Options Cardiovasc Med 1999;1:269-276. https://doi.org/10.1007/s11936-999-0043-3
  2. Nelson RW, Couto CG. Small Animal Internal Medicine. 5th ed. Elsevier/Mosby, St. Louis, 2014.
  3. Ettinger SJ, Feldman EC, Cote E. Textbook of Veterinary Internal Medicine: Diseases of the Dog and the Cat. 8th ed. Elsevier, St. Louis, 2017.
  4. Prewitt RM, McCarthy J, Wood LD. Treatment of acute low pressure pulmonary edema in dogs: relative effects of hydrostatic and oncotic pressure, nitroprusside, and positive end-expiratory pressure. J Clin Invest 1981;67:409-418. https://doi.org/10.1172/JCI110049
  5. Goutal CM, Keir I, Kenney S, Rush JE, Freeman LM. Evaluation of acute congestive heart failure in dogs and cats: 145 cases (2007-2008). J Vet Emerg Crit Care (San Antonio) 2010;20: 330-337. https://doi.org/10.1111/j.1476-4431.2010.00524.x
  6. Graham CA. Pharmacological therapy of acute cardiogenic pulmonary oedema in the emergency department. Emerg Med Australas 2004;16:47-54.
  7. Kirk JD, Parissis JT, Filippatos G. Pharmacologic stabilization and management of acute heart failure syndromes in the emergency department. Heart Fail Clin 2009;5:43-54. https://doi.org/10.1016/j.hfc.2008.08.003
  8. Hollenberg SM. Vasodilators in acute heart failure. Heart Fail Rev 2007;12:143-147. https://doi.org/10.1007/s10741-007-9017-2
  9. Piper S, McDonagh T. The role of intravenous vasodilators in acute heart failure management. Eur J Heart Fail 2014;16:827-834. https://doi.org/10.1002/ejhf.123
  10. Oyama MA, Sisson DD. Cardiac troponin-I concentration in dogs with cardiac disease. J Vet Intern Med 2004;18:831-839. https://doi.org/10.1111/j.1939-1676.2004.tb02629.x
  11. Sleeper MM, Clifford CA, Laster LL. Cardiac troponin I in the normal dog and cat. J Vet Intern Med 2001;15:501-503. https://doi.org/10.1111/j.1939-1676.2001.tb01582.x
  12. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined: a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36:959-969 https://doi.org/10.1016/S0735-1097(00)00804-4